Background Associations between selenium and cancer have directed attention to role of selenoproteins in the carcinogenic process. Methods We used data from two population-based case-control studies of colon (n = 1555 cases, 1956 controls) and rectal (n = 754 cases, 959 controls) cancer. We evaluated the association between genetic variation in TXNRD1, TXNRD2, TXNRD3, C11orf31 (SelH), SelW, SelN1, SelS, SepX, and SeP15 with colorectal cancer risk. Results After adjustment for multiple comparisons, several associations were observed. Two SNPs in TXNRD3 were associated with rectal cancer (rs11718498 dominant OR 1.42 95% CI 1.16,1.74 pACT 0.0036 and rs9637365 recessive 0.70 95% CI 0.55,0.90 pACT 0.0208). Four SNPs in SepN1 were associated with rectal cancer (rs11247735 recessive OR 1.30 95% CI 1.04,1.63 pACT 0.0410; rs2072749 GGvsAA OR 0.53 95% CI 0.36,0.80 pACT 0.0159; rs4659382 recessive OR 0.58 95% CI 0.39,0.86 pACT 0.0247; rs718391 dominant OR 0.76 95% CI 0.62,0.94 pACT 0.0300). Interaction between these genes and exposures that could influence these genes showed numerous significant associations after adjustment for multiple comparisons. Two SNPs in TXNRD1 and four SNPs in TXNRD2 interacted with aspirin/NSAID to influence colon cancer; one SNP in TXNRD1, two SNPs in TXNRD2, and one SNP in TXNRD3 interacted with aspirin/NSAIDs to influence rectal cancer. Five SNPs in TXNRD2 and one in SelS, SeP15, and SelW1 interacted with estrogen to modify colon cancer risk; one SNP in SelW1 interacted with estrogen to alter rectal cancer risk. Several SNPs in this candidate pathway influenced survival after diagnosis with colon cancer (SeP15 and SepX1 increased HRR) and rectal cancer (SepX1 increased HRR). Conclusions Findings support an association between selenoprotein genes and colon and rectal cancer development and survival after diagnosis. Given the interactions observed, it is likely that the impact of cancer susceptibility from genotype is modified by lifestyle.
References
[1]
Gresner P, Gromadzinska J, Jablonska E, Kaczmarski J, Wasowicz W (2009) Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer. Lung Cancer 65: 34–40.
[2]
Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. Jama 276: 1957–1963.
[3]
Peters U, Chatterjee N, Church TR, Mayo C, Sturup S, et al. (2006) High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev 15: 315–320.
[4]
Shchedrina VA, Zhang Y, Labunskyy VM, Hatfield DL, Gladyshev VN (2010) Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Antioxid Redox Signal 12: 839–849.
[5]
Burk RF, Hill KE, Motley AK (2003) Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr 133: 1517S–1520S.
[6]
Behne D, Kyriakopoulos A (2001) Mammalian selenium-containing proteins. Annu Rev Nutr 21: 453–473.
[7]
Lothrop AP, Ruggles EL, Hondal RJ (2009) No selenium required: reactions catalyzed by mammalian thioredoxin reductase that are independent of a selenocysteine residue. Biochemistry 48: 6213–6223.
[8]
Poerschke RL, Moos PJ (2011) Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction. Biochemical pharmacology 81: 211–221.
[9]
Sibbing D, Pfeufer A, Perisic T, Mannes AM, Fritz-Wolf K, et al. (2011) Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. European heart journal 32: 1121–1133.
[10]
Arner ES (2009) Focus on mammalian thioredoxin reductases–important selenoproteins with versatile functions. Biochimica et biophysica acta 1790: 495–526.
[11]
Arner ES (2009) Focus on mammalian thioredoxin reductases–important selenoproteins with versatile functions. Biochim Biophys Acta 1790: 495–526.
[12]
Kumaraswamy E, Malykh A, Korotkov KV, Kozyavkin S, Hu Y, et al. (2000) Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology. J Biol Chem 275: 35540–35547.
[13]
Kim YJ, Chai YG, Ryu JC (2005) Selenoprotein W as molecular target of methylmercury in human neuronal cells is down-regulated by GSH depletion. Biochem Biophys Res Commun 330: 1095–1102.
[14]
Meplan C, Hesketh J (2012) The influence of selenium and selenoprotein gene variants on colorectal cancer risk. Mutagenesis 27: 177–186.
[15]
Fradejas N, Serrano-Perez Mdel C, Tranque P, Calvo S (2011) Selenoprotein S expression in reactive astrocytes following brain injury. Glia 59: 959–972.
[16]
Haug U, Poole EM, Xiao L, Curtin K, Duggan D, et al. (2012) Glutathione peroxidase tagSNPs: Associations with rectal cancer but not with colon cancer. Genes, chromosomes & cancer.
[17]
Slattery MLLA, Welbourn B, Wolff RK, Corcoran C (2012) Oxidative Balance and Colon and Rectal Cancer: Interaction of lifestyle factors and genes. Mutation Research.
[18]
Damdimopoulos AE, Miranda-Vizuete A, Treuter E, Gustafsson JA, Spyrou G (2004) An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling. J Biol Chem 279: 38721–38729.
[19]
Zhou X, Smith AM, Failla ML, Hill KE, Yu Z (2011) Estrogen status alters tissue distribution and metabolism of selenium in female rats. J Nutr Biochem.
[20]
Irons R, Tsuji PA, Carlson BA, Ouyang P, Yoo MH, et al. (2010) Deficiency in the 15-kDa selenoprotein inhibits tumorigenicity and metastasis of colon cancer cells. Cancer Prev Res (Phila) 3: 630–639.
[21]
Slattery ML, Potter J, Caan B, Edwards S, Coates A, et al. (1997) Energy balance and colon cancer–beyond physical activity. Cancer Res 57: 75–80.
[22]
Slattery ML, Edwards S, Curtin K, Ma K, Edwards R, et al. (2003) Physical activity and colorectal cancer. Am J Epidemiol 158: 214–224.
[23]
Edwards S, Slattery ML, Mori M, Berry TD, Caan BJ, et al. (1994) Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 140: 1020–1028.
[24]
Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, et al. (1994) A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 94: 761–766.
[25]
Liu K, Slattery M, Jacobs D, Cutter G, McDonald A, et al. (1994) A study of the reliability and comparative validity of the cardia dietary history. Ethn Dis 4: 15–27.
[26]
Conneely KN, Boehnke M (2007) So Many Correlated Tests, So Little Time! Rapid Adjustment of P Values for Multiple Correlated Tests. Am J Hum Genet 81: 1158–1168.
[27]
Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6: 65–70.
[28]
Westfall PH, Zaykin DV, Young SS (2002) Multiple tests for genetic effects in association studies. Methods Mol Biol 184: 143–168.
[29]
Welbourn B (2012) An exact approach to testing for gene-environment interactions. Logan: Utah State University.
[30]
Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, et al. (2005) Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129: 837–845.
[31]
Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, et al. (2001) Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 10: 917–923.
[32]
Slattery ML, Anderson K, Curtin K, Ma K, Schaffer D, et al. (2001) Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res 483: 73–81.
[33]
Slattery ML, Curtin K, Ma K, Edwards S, Schaffer D, et al. (2002) Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev 541–548.
[34]
Zhu X, Huang C, Peng B (2011) Overexpression of thioredoxin system proteins predicts poor prognosis in patients with squamous cell carcinoma of the tongue. Oral Oncol 47: 609–614.
[35]
Sun QA, Wu Y, Zappacosta F, Jeang KT, Lee BJ, et al. (1999) Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J Biol Chem 274: 24522–24530.
[36]
Schenk H, Klein M, Erdbrugger W, Droge W, Schulze-Osthoff K (1994) Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci U S A 91: 1672–1676.
[37]
Peters U, Chatterjee N, Hayes RB, Schoen RE, Wang Y, et al. (2008) Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev 17: 1144–1154.
[38]
Meplan C, Hughes DJ, Pardini B, Naccarati A, Soucek P, et al. (2010) Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis 31: 1074–1079.
[39]
Hesketh J, Meplan C (2011) Transcriptomics and functional genetic polymorphisms as biomarkers of micronutrient function: focus on selenium as an exemplar. Proc Nutr Soc 1–9.
[40]
Slattery ML, Caan BJ, Benson J, Murtaugh M (2003) Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr Cancer 46: 166–171.
